IQ and Frax collaborate to launch the KRWQ Korean won stablecoin based on the Base network
PANews, October 30—According to The Block, IQ and Frax jointly announced on Thursday the launch of KRWQ, a stablecoin pegged to the Korean won (KRW). The two companies stated in a press release that with the launch of the KRWQ-USDC trading pair on the Aerodrome platform, KRWQ becomes the first Korean won-pegged stablecoin on Coinbase’s Ethereum Layer 2 network Base. Reportedly, KRWQ is also the first multi-chain token pegged to the Korean won, adopting LayerZero’s Omnichain Fungible Token (OFT) standard and utilizing the Stargate cross-chain bridge to enable token transfers across multiple blockchains. IQ announced that it will draw on Frax’s expertise in regulatory compliance, particularly its experience with frxUSD, for the design of KRWQ to support institutional adoption and due diligence. Meanwhile, as South Korea is still working to establish basic rules for stablecoins, KRWQ has not yet been marketed or offered to residents in South Korea. The minting and redemption of this stablecoin are also limited to eligible counterparties, such as exchanges, market makers, and institutional partners.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market
CoreWeave's unsecured bonds have replaced Nvidia as the market's "beta barometer" for measuring AI trades. The bonds’ yields have surged past 16% and CDS spreads have soared, highlighting the high dependence of emerging cloud computing companies on debt financing and their funding gap risks. Credit pressures are spreading from infrastructure to equity markets, and the main focus of AI trading has shifted from computing power demand to financing costs and sustainability.
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window
The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.
After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"
Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.
Roadster is just an appetizer? Renowned investor predicts: SpaceX (SPCX.US) may announce the acquisition of Tesla (TSLA.US) within weeks at $420 per share
Gary Black, Managing Director of the Future Fund, recently tweeted a prediction that SpaceX may announce an all-stock acquisition of Tesla within weeks and view the launch of the flying edition Roadster as an opportunity to integrate Elon Musk's companies.
Crypto prices
More
